Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kotera

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioscience, Biotechnology, and Biochemistry|June 10, 2016
Characteristic and Localization of the Monitor Peptide ReceptorR Yamanishi, J Kotera, T Fushiki, et al.
European Journal of Biochemistry|April 1, 1996
Structure of the 5'-flanking regulatory region of the mouse gene encoding the clearance receptor for atrial natriuretic peptideN Yanaka, J Kotera, I Taguchi, et al.
Journal of Medicinal Chemistry|April 10, 1999
1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitorT Ukita, Y Nakamura, A Kubo, et al.
The Journal of Biological Chemistry|June 22, 1999
Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)K Fujishige, J Kotera, H Michibata, et al.
Biochemical Pharmacology|September 29, 2000
Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5)J Kotera, K Fujishige, H Michibata, et al.
European Journal of Biochemistry|November 25, 1997
Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal developmentJ Kotera, N Yanaka, K Fujishige, et al.
European Journal of Biochemistry|July 20, 1999
Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterasesJ Kotera, K Fujishige, Y Imai, et al.
The Biochemical Journal|April 1, 1993
A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cellsR Yamanishi, J Kotera, T Fushiki, et al.
Clinical and Experimental Immunology|June 18, 2002
Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitorsA Nakata, K Ogawa, T Sasaki, et al.
Journal of Medicinal Chemistry|June 19, 2001
Novel, potent, and selective phosphodiesterase 5 inhibitors: synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivativesT Ukita, Y Nakamura, A Kubo, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioscience, Biotechnology, and Biochemistry|June 10, 2016
Characteristic and Localization of the Monitor Peptide ReceptorR Yamanishi, J Kotera, T Fushiki, et al.
European Journal of Biochemistry|April 1, 1996
Structure of the 5'-flanking regulatory region of the mouse gene encoding the clearance receptor for atrial natriuretic peptideN Yanaka, J Kotera, I Taguchi, et al.
Journal of Medicinal Chemistry|April 10, 1999
1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitorT Ukita, Y Nakamura, A Kubo, et al.
The Journal of Biological Chemistry|June 22, 1999
Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)K Fujishige, J Kotera, H Michibata, et al.
Biochemical Pharmacology|September 29, 2000
Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5)J Kotera, K Fujishige, H Michibata, et al.
European Journal of Biochemistry|November 25, 1997
Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal developmentJ Kotera, N Yanaka, K Fujishige, et al.
European Journal of Biochemistry|July 20, 1999
Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterasesJ Kotera, K Fujishige, Y Imai, et al.
The Biochemical Journal|April 1, 1993
A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cellsR Yamanishi, J Kotera, T Fushiki, et al.
Clinical and Experimental Immunology|June 18, 2002
Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitorsA Nakata, K Ogawa, T Sasaki, et al.
Journal of Medicinal Chemistry|June 19, 2001
Novel, potent, and selective phosphodiesterase 5 inhibitors: synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivativesT Ukita, Y Nakamura, A Kubo, et al.
Pageof 3